*ST豆神(300010) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was CNY 226,990,577.71, representing a year-over-year increase of 28.93%[3] - Net profit attributable to shareholders for Q3 2024 was CNY 41,779,707.58, showing a significant increase of 191.98% compared to the same period last year[3] - The basic earnings per share for Q3 2024 was CNY 0.0210, reflecting a 140.06% increase year-over-year[3] - Total operating revenue for Q3 2024 was CNY 557.02 million, a decrease of 13% from CNY 639.74 million in the same period last year[12] - Net profit for Q3 2024 was CNY 109.19 million, compared to a net loss of CNY 105.70 million in Q3 2023[15] - Basic earnings per share for Q3 2024 was CNY 0.0556, recovering from a loss of CNY 0.1163 in the previous year[16] Assets and Liabilities - Total assets as of September 30, 2024, were CNY 1,930,101,009.20, a decrease of 34.74% from the end of the previous year[3] - The company reported a total liability of CNY 910.11 million, a decrease of 56% from CNY 2.06 billion year-over-year[12] - The total number of common shareholders at the end of the reporting period is 47,974, with the top 10 shareholders holding 47.74% of the shares[7] - The company approved the sale of 100% equity of its subsidiary for ¥4 million, indicating a strategic divestment[9] - The total liabilities decreased, with short-term borrowings dropping to ¥5,682,367.42 from ¥21,768,978.41[11] Cash Flow - The company's cash flow from operating activities for the year-to-date was CNY 24,158,257.61, an increase of 165.34% compared to the same period last year[6] - The net cash flow from operating activities for the current period is $24,158,257.61, compared to a negative cash flow of $36,971,826.54 in the previous period, indicating a significant improvement[18] - Total cash inflow from operating activities decreased to $658,640,803.00 from $772,808,982.29, a decline of approximately 14.7% year-over-year[17] - Cash outflow from operating activities totaled $634,482,545.39, down from $809,780,808.83, representing a reduction of about 21.6%[18] - The company reported a cash and cash equivalents balance of $82,095,275.31 at the end of the period, compared to $65,460,539.61 at the end of the previous period, marking an increase of about 25.3%[18] Expenses - Research and development expenses for Q3 2024 were CNY 14,734,174.78, a decrease of 33.78% from the previous year[6] - Total operating costs decreased to CNY 492.03 million, down 32% from CNY 727.38 million year-over-year[15] - Financial expenses showed a significant improvement, with a net income of CNY 36.21 million compared to a loss of CNY 71.22 million in the previous year[15] Shareholder Information - Dou Xin, a natural person, holds 18.29% of the shares, amounting to 378,068,362 shares, with 4,500,000 shares pledged[7] - The company has not reported any changes in the participation of major shareholders in margin financing and securities lending[8] Audit and Compliance - The company did not undergo an audit for the Q3 2024 report[2] - The company has not undergone an audit for the third quarter report, which may affect the perception of financial reliability[20] Future Outlook - Future outlook includes continued focus on market expansion and new product development to drive revenue growth[15]